Drugs / Colloidal Oatmeal Balm
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT02691507 | Feb → Apr 2016 | atopic eczema | Johnson & Johnson Consumer Inc. (J&JCI) | Completed | Missed primary |
| Phase not applicable2 trials · 1 met primary | ||||||
| — | NCT02404493 | Mar 2015 → Mar 2016 | atopic eczema | Johnson & Johnson Consumer Inc. (J&JCI) | Terminated | Met primary Stop: Enrollment |
| — | NCT02357940 | Jan 2015 → Jan 2016 | atopic eczema | Johnson & Johnson Consumer Inc. (J&JCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Colloidal Oatmeal Balm | “1% Colloidal Oatmeal Balm” NCT02357940 ↗ |
| Modality | Other / unclassified | “new over-the-counter moisturizing balm” NCT02357940 ↗ |
| Route | Topical | “Apply thin layer of experimental product to the affected skin areas at least 2 times per day and massage gently into skin” NCT02357940 ↗ |